Primary |
Breast Cancer |
61.2% |
Breast Cancer Female |
11.3% |
Hypertension |
7.5% |
Osteoporosis |
2.0% |
Breast Cancer Metastatic |
1.7% |
Diabetes Mellitus |
1.7% |
Depression |
1.6% |
Pain |
1.6% |
Prophylaxis |
1.4% |
Hypothyroidism |
1.4% |
Hypercholesterolaemia |
1.3% |
Gastrooesophageal Reflux Disease |
1.0% |
Breast Cancer Stage I |
0.9% |
Anxiety |
0.9% |
Insomnia |
0.9% |
Neoplasm Malignant |
0.8% |
Breast Cancer Recurrent |
0.7% |
Blood Pressure |
0.7% |
Blood Cholesterol Increased |
0.7% |
Sleep Disorder |
0.7% |
|
Weight Increased |
17.5% |
Pain In Extremity |
8.8% |
Death |
6.9% |
Weight Decreased |
6.7% |
Neoplasm Malignant |
5.5% |
Trigger Finger |
5.0% |
Hot Flush |
4.7% |
Pain |
4.7% |
Nausea |
4.7% |
Malaise |
4.0% |
Paraesthesia |
3.9% |
Myalgia |
3.4% |
Vomiting |
3.3% |
Osteoporosis |
3.2% |
Neuropathy Peripheral |
3.1% |
Ill-defined Disorder |
3.1% |
Vulvovaginal Dryness |
3.1% |
Arthralgia |
2.9% |
Oedema Peripheral |
2.8% |
Insomnia |
2.7% |
|
Secondary |
Breast Cancer |
46.7% |
Breast Cancer Metastatic |
9.3% |
Product Used For Unknown Indication |
6.8% |
Hypertension |
6.4% |
Drug Use For Unknown Indication |
6.0% |
Breast Cancer Female |
5.8% |
Pain |
2.2% |
Osteoporosis |
2.0% |
Metastases To Bone |
1.7% |
Her-2 Positive Breast Cancer |
1.6% |
Depression |
1.4% |
Gastrooesophageal Reflux Disease |
1.3% |
Prophylaxis |
1.3% |
Hypercalcaemia |
1.2% |
Hypothyroidism |
1.1% |
Sleep Disorder |
1.1% |
Blood Pressure Abnormal |
1.1% |
Blood Cholesterol Increased |
1.0% |
Osteopenia |
1.0% |
Diabetes Mellitus |
0.9% |
|
Weight Increased |
14.8% |
Trigger Finger |
6.9% |
Weight Decreased |
6.0% |
Hot Flush |
5.4% |
Nausea |
5.4% |
Pulmonary Embolism |
5.4% |
Myocardial Infarction |
5.0% |
Paraesthesia |
4.7% |
Vomiting |
4.7% |
Wound Infection Staphylococcal |
4.7% |
Pain |
4.4% |
Arthralgia |
4.1% |
Pain In Extremity |
4.1% |
Sudden Death |
4.1% |
Weight Loss Poor |
3.8% |
Breast Cancer |
3.5% |
Myalgia |
3.5% |
Tumour Marker Increased |
3.5% |
Osteonecrosis |
3.2% |
Malaise |
2.8% |
|
Concomitant |
Breast Cancer |
26.0% |
Metastases To Bone |
14.5% |
Drug Use For Unknown Indication |
8.9% |
Breast Cancer Metastatic |
8.7% |
Product Used For Unknown Indication |
8.3% |
Hypertension |
4.7% |
Prophylaxis |
4.1% |
Osteoporosis |
3.8% |
Depression |
3.7% |
Pain |
3.3% |
Gastrooesophageal Reflux Disease |
1.8% |
Anxiety |
1.7% |
Neoplasm Malignant |
1.6% |
Diabetes Mellitus |
1.5% |
Chemotherapy |
1.5% |
Rheumatoid Arthritis |
1.4% |
Type 2 Diabetes Mellitus |
1.1% |
Bone Pain |
1.1% |
Blood Cholesterol Increased |
1.0% |
Anaemia |
1.0% |
|
Weight Decreased |
15.7% |
Tooth Extraction |
12.6% |
Vomiting |
9.1% |
Weight Increased |
8.5% |
Wound Drainage |
6.0% |
Osteonecrosis |
5.3% |
Breast Cancer |
3.7% |
Wheezing |
3.5% |
Toothache |
3.4% |
Urinary Tract Infection |
3.3% |
White Blood Cell Count Decreased |
3.3% |
Death |
3.2% |
Rash |
3.1% |
Wheelchair User |
3.0% |
Wound |
3.0% |
Wound Treatment |
2.9% |
Pneumonia |
2.7% |
Wound Debridement |
2.7% |
Vision Blurred |
2.5% |
Fatigue |
2.4% |
|
Interacting |
Breast Cancer |
55.6% |
Nervousness |
12.1% |
Convulsion |
4.0% |
Hallucination |
4.0% |
Breast Cancer Metastatic |
3.0% |
Mania |
3.0% |
Metastasis |
3.0% |
Cryptogenic Organising Pneumonia |
2.0% |
Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
Anxiety |
1.0% |
Axillary Mass |
1.0% |
Bipolar Disorder |
1.0% |
Bone Density Decreased |
1.0% |
Chronic Myeloid Leukaemia |
1.0% |
Constipation |
1.0% |
Deep Vein Thrombosis |
1.0% |
Depression |
1.0% |
Endometriosis |
1.0% |
Myocardial Ischaemia |
1.0% |
Neoplasm Prophylaxis |
1.0% |
|
Weight Decreased |
23.8% |
Throat Tightness |
19.0% |
Hepatic Enzyme Increased |
9.5% |
Pulmonary Embolism |
9.5% |
Headache |
4.8% |
Impaired Gastric Emptying |
4.8% |
Insomnia |
4.8% |
Osteonecrosis |
4.8% |
Thrombophlebitis |
4.8% |
Tremor |
4.8% |
Urticaria |
4.8% |
Vaginal Haemorrhage |
4.8% |
|